Edition:
United States

SciClone Pharmaceuticals Inc (SCLN.OQ)

SCLN.OQ on NASDAQ Stock Exchange Global Select Market

10.25USD
7 Dec 2016
Change (% chg)

$-0.25 (-2.38%)
Prev Close
$10.50
Open
$10.35
Day's High
$10.50
Day's Low
$10.15
Volume
66,326
Avg. Vol
117,130
52-wk High
$15.02
52-wk Low
$7.39

SCLN.OQ

Chart for SCLN.OQ

About

SciClone Pharmaceuticals, Inc. is a pharmaceutical company. The Company's product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders. The Company operates in two segments: China and the Rest of the World, including its operations in the United States and Hong Kong. The Company's lead... (more)
No analyst recommendations are available for SCLN.OQ.

Overall

Beta: 1.68
Market Cap(Mil.): $536.06
Shares Outstanding(Mil.): 51.05
Dividend: --
Yield (%): --

Financials

  SCLN.OQ Industry Sector
P/E (TTM): 14.03 30.14 30.77
EPS (TTM): 0.75 -- --
ROI: 19.67 15.85 15.23
ROE: 19.68 16.96 16.56

BRIEF-Sciclone says received unsolicited proposal from GL Capital and ABG Management

* Sciclone confirms receipt of unsolicited proposal from GL Capital and ABG Management

Nov 14 2016

BRIEF-Gl management and its affiliates submit proposal to board of Sciclone Pharmaceuticals

* Gl Management And Its Affiliates submit proposal to board of Sciclone Pharmaceuticals Inc to buyout the Co at $11.18 per share in cash

Nov 14 2016

BRIEF-Man Group posts 5.13 pct stake in SciClone Pharmaceuticals as of Sept. 16 - SEC Filing

* Man Group Plc reports 5.13 pct passive stake in SciClone Pharmaceuticals as of September 16, 2016 - SEC Filing Source text for Eikon: (http://bit.ly/2dd9CDi) Further company coverage:

Sep 22 2016

BRIEF-Sciclone Pharmaceuticals plans to remain independent publicly traded company

* No longer continuing active discussions with potential acquirers

Jul 19 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $111.10 -0.96
Novartis AG (NOVN.S) CHF68.75 --
Pfizer Inc. (PFE.N) $31.19 -0.37
Merck & Co., Inc. (MRK.N) $60.06 -0.22
Amgen, Inc. (AMGN.OQ) $141.19 -3.92
Gilead Sciences, Inc. (GILD.OQ) $72.78 +0.31

Earnings vs. Estimates